Joint Commission Issues Alert Concerning Blood Thinners

The Joint Commission has issued a Sentinel Event Alert concerning the use of blood thinners following several high profile errors related to their use.

Advertisement

From 1997-2007, there were 31 reported sentinel events related to anticoagulants affecting 34 patients. Of these 34 patients, 28 died.

The alert offers 15 specific steps to help organizations reduce the risk to patients from incorrect administering, the use of the wrong drug or other causes of anticoagulation-related sentinel events. These steps, which cover suggestions for use of all anticoagulants, and also actions just for heparin and warfarin, include:

  • Assess the risks of using anticoagulants.
  • Use best practices or evidence-based guidelines regarding anticoagulants.
  • Establish standard dose limits on anticoagulants and require that a doctor confirm any exceptions.
  • Clearly label syringes and other containers used for anticoagulants.
  • Clarify all anticoagulant dosing for pediatric patients, who are higher risk because these drugs are formulated and packaged for adults.

Read The Joint Commission’s anticoagulation Sentinel Event Alert.

Learn more about The Joint Commission.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in ASC Accreditation, Licensure & Medicare Certification

Advertisement

Comments are closed.